LB-100 Uses, Dosage, Side Effects and more

LB-100 is under investigation in clinical trial NCT03886662 (A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)).

Attribute	Details
Trade Name	LB-100
Generic	LB-100
Type
Formula	C13H20N2O4
Weight	Average: 268.313 Monoisotopic: 268.142307132
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph